4th Annual Immunogenicity and Tolerance Seminar

Friday November 09 2018

Leiden University, Gate Building Leiden


This seminar will center around current translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics.

To date the committee has confirmed the attendance of the following speakers: 

Willem van Eden, MD, PhD - Utrecht University
“Tolerogenic Dendritic cells as therapy for Rheumatoid Arthritis”

Tom Ottenhof, MD, PhD - Leiden University Medical Center
"New vaccination and therapeutic strategies against bacterial infectious diseases"

Rebecca Ashfield, PhD - Oxford University
RH5: a candidate vaccine for blood stage P falciparum malaria

Rene Raeven, PhD - Intravacc
“Effect of vaccine composition and immunization route on induction of innate immune responses and adaptive immunity against Bordetella pertussis”

Vibha Jawa, PhD - Merck
“Mechanisms behind immune response to minor impurities and their ability to break tolerance”

Amy Rosenberg, MD - United States Food and Drug Administration/Center for Drug Evaluation and Research
TBD

This event is co-organized by the Leiden Academic Centre for Drug Research (LACDR), the Institute for Immunology and Informatics (University of Rhode Island) and EpiVax, Inc. The Scientific Committee includes Drs. Wim Jiskoot (LACDR), Bram Slütter (LACDR), Marieke van Ham (Sanquin), and Annie De Groot (EpiVax).

Interested in attending this seminar? Please register for the event here.

print this page
 
Webdesign © 2008 Strik Design